Author

Sarwar Islam Mozumder

Observed names: Mozumder, Sarwar I., Sarwar I. Mozumder

Institutions: AstraZeneca (United Kingdom), University of Leicester, GlaxoSmithKline (United Kingdom), GlaxoSmithKline Research & Development Limited (United Kingdom)

Observed institutions: AstraZeneca (United Kingdom), University of Leicester, GlaxoSmithKline (United Kingdom), GlaxoSmithKline Research & Development Limited (United Kingdom)

ORCID: 0000-0001-9644-7525

Observed ORCID: 0000-0001-9644-7525

OpenAlex ID: A5011445589

Minimum sample size calculations for external validation of a clinical prediction model with a time‐to‐event outcome

2021 · Richard D. Riley, Gary S. Collins, et al. · Statistics in Medicine · 129

Robustness of individual and marginal model-based estimates: A sensitivity analysis of flexible parametric models

2018 · Elisavet Syriopoulou, Sarwar I. Mozumder, et al. · Cancer Epidemiology · 52

A Flexible Parametric Competing-risks Model Using a Direct Likelihood Approach for the Cause-specific Cumulative Incidence Function

2017 · Sarwar Islam Mozumder, Mark J. Rutherford, et al. · The Stata Journal Promoting communications on statistics and Stata · 51

Estimating restricted mean survival time and expected life-years lost in the presence of competing risks within flexible parametric survival models

2021 · Sarwar I. Mozumder, Mark J. Rutherford, et al. · BMC Medical Research Methodology · 35

stpm2cr: A flexible parametric competing risks model using a direct likelihood approach for the cause-specific cumulative incidence function.

2017 · Sarwar Islam Mozumder, Mark J Rutherford, et al. · PubMed · 31

Direct likelihood inference on the cause‐specific cumulative incidence function: A flexible parametric regression modelling approach

2017 · Sarwar Islam Mozumder, Mark Rutherford, et al. · Statistics in Medicine · 25

Estimating causal effects in the presence of competing events using regression standardisation with the Stata command standsurv

2022 · Elisavet Syriopoulou, Sarwar I. Mozumder, et al. · BMC Medical Research Methodology · 24

InterPreT cancer survival: A dynamic web interactive prediction cancer survival tool for health-care professionals and cancer epidemiologists

2018 · Sarwar Islam Mozumder, Paul W. Dickman, et al. · Cancer Epidemiology · 16

Conditional crude probabilities of death for English cancer patients

2019 · Kwok F. Wong, Paul C. Lambert, et al. · British Journal of Cancer · 13

Using temporal recalibration to improve the calibration of risk prediction models in competing risk settings when there are trends in survival over time

2023 · Sarah Booth, Sarwar I. Mozumder, et al. · Statistics in Medicine · 10

Current practice on covariate adjustment and stratified analysis —based on survey results by ASA oncology estimand working group conditional and marginal effect task force

2025 · Jiawei Wei, Sarwar I. Mozumder, et al. · BMC Medical Research Methodology · 5

Calibration of cause-specific absolute risk for external validation using each cause-specific hazards model in the presence of competing events

2025 · Sarwar I. Mozumder, Sarah Booth, et al. · Diagnostic and Prognostic Research · 5

Time-to-Event Estimands in Oncology Trials: What’s Censoring Got To Do, Got To Do With It?

2025 · Sarwar I. Mozumder, Lynda Grinsted, et al. · Statistics in Biopharmaceutical Research · 1

Analysing time-to-event data in the presence of competing risks within the flexible parametric modelling framework. What tools are available in Stata, which one to use and when?

2018 · Sarwar Islam Mozumder · RePEc: Research Papers in Economics

Works count: 16

Citation count: 397

H-index: 10

I10-index: 10